Carvedilol Supplier-Buyer Network — Trade Flow Analysis

Name: Carvedilol Supplier-Buyer Trade Network Dataset — 242+ Indian Exporters, 17+ Importers, 98+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Carvedilol supplier network, Carvedilol buyers, pharmaceutical export India, Carvedilol trade data

TransData Nexus

Carvedilol

India Pharmaceutical Trade Intelligence

$98.1M242 Suppliers98 CountriesHS 30049079

ExportsIndia → UNITED STATES60.1%India → ECUADOR16.5%

ImportsUNITED STATES → India$74.1K CANADA → India$35.1K

#1 Supplier: ZYDUS LIFESCIENCES #1 Buyer: EVERSANA LIFE

Who Supplies Carvedilol? Top Manufacturers & Buyers 2026 — ZYDUS LIFESCIENCES LIMITED Leads | TransData Nexus | TransData Nexus

1ZYDUS LIFESCIENCES LIMITED

ZYDUS LIFESCIENCES LIMITED is the first-largest Carvedilol exporter from India, with a market share of 20.1% and a total export value of $19.7M across 656 shipments. Their average shipment value of $30.0K is above the market average of $20.6K, suggesting premium or bulk contract pricing.

ZYDUS LIFESCIENCES LIMITED serves 5 named buyers in our database. EVERSANA LIFE SCIENCE SERVICES LLC is the dominant customer, accounting for 79.4% of this supplier's tracked business. Top customers include:

• EVERSANA LIFE SCIENCE SERVICES LLC — $15.6M across 521 shipments (79.4% of this supplier's total exports)

• AMERISOURCE HEALTH SERVICES DBA AMERICAN HEALTH — $2.9M across 96 shipments (14.6% of this supplier's total exports)

• PRIORITY HEALTHCARE DISTRIBUTION — $719.2K across 24 shipments (3.7% of this supplier's total exports)

• AMERISOURCE HEALTH SERVICES DBA AMERICAN HEALTH — $258.3K across 9 shipments (1.3% of this supplier's total exports)

• SUNSHINE HEALTHCARE — $208.3K across 7 shipments (1.1% of this supplier's total exports)

Key Insight: ZYDUS LIFESCIENCES LIMITED's per-shipment value of $30.0K is 45% above the market average of $20.6K, consistent with large-order contracts or value-added formulations.

2CARITAS HEALTHCARE PRIVATE LIMITED

CARITAS HEALTHCARE PRIVATE LIMITED is the second-largest Carvedilol exporter from India, with a market share of 16.2% and a total export value of $15.8M across 29 shipments. Their average shipment value of $546.5K is above the market average of $20.6K, suggesting premium or bulk contract pricing.

CARITAS HEALTHCARE PRIVATE LIMITED serves 4 named buyers in our database. TO THE PURCHASE MANAGER is the dominant customer, accounting for 96.4% of this supplier's tracked business. Top customers include:

• TO THE PURCHASE MANAGER — $15.3M across 28 shipments (96.4% of this supplier's total exports)

• F.D.E.C.A — $370.1K across 1 shipments (2.3% of this supplier's total exports)

• FDECA QUITO ECUADOR — $160.5K across 0 shipments (1.0% of this supplier's total exports)

• F.D.E.C.A — $47.4K across 0 shipments (0.3% of this supplier's total exports)

Key Insight: CARITAS HEALTHCARE PRIVATE LIMITED's per-shipment value of $546.5K is 2547% above the market average of $20.6K, consistent with large-order contracts or value-added formulations.

3CIPLA LIMITED

CIPLA LIMITED is the third-largest Carvedilol exporter from India, with a market share of 6.9% and a total export value of $6.8M across 28 shipments. Their average shipment value of $243.1K is above the market average of $20.6K, suggesting premium or bulk contract pricing.

CIPLA LIMITED serves 5 named buyers in our database. CIPLAMEDICA PHARMACEUTICAL INDUSTRI is the dominant customer, accounting for 97.5% of this supplier's tracked business. Top customers include:

• CIPLAMEDICA PHARMACEUTICAL INDUSTRI — $6.6M across 27 shipments (97.5% of this supplier's total exports)

• PROFON S A — $64.9K across 0 shipments (1.0% of this supplier's total exports)

• MEDICA PHARMACEUTICA — $40.6K across 0 shipments (0.6% of this supplier's total exports)

• CIPLAMEDICA PHARMACEUTICAL INDUSTRI — $35.6K across 0 shipments (0.5% of this supplier's total exports)

• PROFON S A — $31.2K across 0 shipments (0.5% of this supplier's total exports)

Key Insight: CIPLA LIMITED's per-shipment value of $243.1K is 1078% above the market average of $20.6K, consistent with large-order contracts or value-added formulations.

4PIRAMAL PHARMA LIMITED

PIRAMAL PHARMA LIMITED is the fourth-largest Carvedilol exporter from India, with a market share of 6.5% and a total export value of $6.4M across 141 shipments. Their average shipment value of $45.4K is above the market average of $20.6K, suggesting premium or bulk contract pricing.

PIRAMAL PHARMA LIMITED serves 3 named buyers in our database. TEVA PHARMACEUTICALS USA INC is the dominant customer, accounting for 64.8% of this supplier's tracked business. Top customers include:

• TEVA PHARMACEUTICALS USA INC — $4.1M across 91 shipments (64.8% of this supplier's total exports)

• TEVA PHARMACEUTICALS USA INC — $1.8M across 40 shipments (28.7% of this supplier's total exports)

• TEVA PHARMACEUTICALS USA INC — $416.4K across 9 shipments (6.5% of this supplier's total exports)

Key Insight: PIRAMAL PHARMA LIMITED's per-shipment value of $45.4K is 120% above the market average of $20.6K, consistent with large-order contracts or value-added formulations.

5GLENMARK PHARMACEUTICALS LIMITED

GLENMARK PHARMACEUTICALS LIMITED is the fifth-largest Carvedilol exporter from India, with a market share of 5.1% and a total export value of $5.0M across 257 shipments. Their average shipment value of $19.3K is below the market average of $20.6K, reflecting a high-volume, competitive pricing strategy.

GLENMARK PHARMACEUTICALS LIMITED serves 5 named buyers in our database. GLENMARK PHARMACEUTICALS INC is the dominant customer, accounting for 57.6% of this supplier's tracked business. Top customers include:

• GLENMARK PHARMACEUTICALS INC — $2.9M across 148 shipments (57.6% of this supplier's total exports)

• GLENMARK PHARMACEUTICALS INC — $825.9K across 43 shipments (16.7% of this supplier's total exports)

• GLENMARK PHARMACEUTICALS INC — $737.0K across 38 shipments (14.9% of this supplier's total exports)

• GLENMARK PHARMACEUTICALS INC — $311.1K across 16 shipments (6.3% of this supplier's total exports)

• GLENMARK PHARMACEUTICALS INC — $226.3K across 12 shipments (4.6% of this supplier's total exports)

Key Insight: GLENMARK PHARMACEUTICALS LIMITED operates with high shipment frequency (257 shipments) at a per-shipment value of $19.3K, indicating a broad distribution network with many smaller, regular orders.

6AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD is the fifth-largest Carvedilol exporter from India, with a market share of 1.5% and a total export value of $1.5M across 484 shipments. Their average shipment value of $3.0K is below the market average of $20.6K, reflecting a high-volume, competitive pricing strategy.

AUROBINDO PHARMA LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• APL SWIFT SERVICES (MALTA) LTD., — $580.4K across 192 shipments (39.6% of this supplier's total exports)

• SIVEM PHARMACEUTICAL — $374.2K across 124 shipments (25.5% of this supplier's total exports)

• DIFEM LABORATORIOS S.A, — $200.6K across 66 shipments (13.7% of this supplier's total exports)

• MILPHARM LIMITED — $199.6K across 66 shipments (13.6% of this supplier's total exports)

• AURO PHARMA INC, — $111.4K across 37 shipments (7.6% of this supplier's total exports)

Key Insight: AUROBINDO PHARMA LTD operates with high shipment frequency (484 shipments) at a per-shipment value of $3.0K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Carvedilol imports from India, with a total trade value of $59.0M across 1,408 shipments — representing a 60.1% share of all Carvedilol exports. The average shipment value of $41.9K is above the global average of $20.6K, indicating high-value procurement contracts or branded formulations. This market is served by 15 tracked buyers.

Named Carvedilol importers in United States: EVERSANA LIFE SCIENCE SERVICES is the largest buyer, accounting for 32.7% ($19.3M) of this market's total imports.

• EVERSANA LIFE SCIENCE SERVICES — $19.3M (32.7% of United States's total)

• TEVA PHARMACEUTICALS USA, INC — $6.5M (11.1% of United States's total)

• GLENMARK PHARMACEUTICALS INC., USA — $6.3M (10.6% of United States's total)

Key Insight: United States's per-shipment average of $41.9K (103% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Carvedilol imports from India.

Primary Market

Secondary Market

2Ecuador

Ecuador ranks as the second-largest destination for Carvedilol imports from India, with a total trade value of $16.2M across 10 shipments — representing a 16.5% share of all Carvedilol exports. The average shipment value of $1.6M is above the global average of $20.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Carvedilol importers in Ecuador: TO THE PURCHASE MANAGER is the largest buyer, accounting for 95.5% ($15.5M) of this market's total imports.

• TO THE PURCHASE MANAGER — $15.5M (95.5% of Ecuador's total)

Key Insight: Ecuador's per-shipment average of $1.6M (7747% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Ecuador is a key market for Carvedilol imports from India.

Primary Market

Secondary Market

3Yemen

Yemen ranks as the third-largest destination for Carvedilol imports from India, with a total trade value of $6.7M across 10 shipments — representing a 6.9% share of all Carvedilol exports. The average shipment value of $672.6K is above the global average of $20.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Carvedilol importers in Yemen: CIPLAMEDICA PHARMACEUTICAL INDUSTRI is the largest buyer, accounting for 98.6% ($6.6M) of this market's total imports.

• CIPLAMEDICA PHARMACEUTICAL INDUSTRI — $6.6M (98.6% of Yemen's total)

Key Insight: Yemen's per-shipment average of $672.6K (3158% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Yemen is a key market for Carvedilol imports from India.

Primary Market

Secondary Market

4Chile

Chile ranks as the fourth-largest destination for Carvedilol imports from India, with a total trade value of $2.0M across 11 shipments — representing a 2.0% share of all Carvedilol exports. The average shipment value of $181.0K is above the global average of $20.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Carvedilol importers in Chile: DIFEM LABORATORIOS S.A, is the largest buyer, accounting for 46.9% ($933.6K) of this market's total imports.

• DIFEM LABORATORIOS S.A, — $933.6K (46.9% of Chile's total)

Key Insight: Chile's per-shipment average of $181.0K (777% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Chile is a key market for Carvedilol imports from India.

Primary Market

Secondary Market

5Philippines

Philippines ranks as the fifth-largest destination for Carvedilol imports from India, with a total trade value of $1.9M across 13 shipments — representing a 2.0% share of all Carvedilol exports. The average shipment value of $148.9K is above the global average of $20.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Carvedilol importers in Philippines: OLLEN PHARMA TRADING INC is the largest buyer, accounting for 47.1% ($911.8K) of this market's total imports.

• OLLEN PHARMA TRADING INC — $911.8K (47.1% of Philippines's total)

Key Insight: Philippines's per-shipment average of $148.9K (621% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Philippines is a key market for Carvedilol imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Carvedilol.
2.Flow Mapping: 242 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 4,750 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 98 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

4,750 Verified Shipments

242 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Carvedilol

Carvedilol

Who Supplies Carvedilol? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Carvedilol? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Carvedilol Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1ZYDUS LIFESCIENCES LIMITED

2CARITAS HEALTHCARE PRIVATE LIMITED

3CIPLA LIMITED

4PIRAMAL PHARMA LIMITED

5GLENMARK PHARMACEUTICALS LIMITED

6AUROBINDO PHARMA LTD

From Indian Factories to Global Pharmacies — How Carvedilol Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Carvedilol Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Ecuador

3Yemen

4Chile

5Philippines

People Also Ask — Carvedilol Supplier & Trade Network

Carvedilol Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology